Ajanta Pharma promoter Aayush Agrawal has filed a comprehensive disclosure with stock exchanges regarding share pledge transactions conducted under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The disclosure, dated 6th March, 2026, outlines multiple pledge creation and release activities involving the promoter's shareholding in the pharmaceutical company.

Share Pledge Transaction Summary

The promoter disclosed creation of pledge on 7,87,933 shares and release of pledge on 8,32,178 shares during the reporting period. The pledge creation was undertaken for additional loan purposes, while the pledge releases were executed for loan repayment and margin reduction activities.

Detailed Transaction Activities

The disclosure reveals multiple transactions conducted between February 24, 2026, and March 5, 2026, involving various financial institutions. Aayush Agrawal Trust, holding 1,41,12,924 shares representing 11.30% of total share capital, executed these transactions across different dates.

Key Transaction Events

February 2026 Transactions:

• February 24, 2026: Released pledge of 2,13,000 shares with Aditya Birla Capital Ltd for loan repayment
• February 27, 2026: Created pledge of 2,13,000 shares with Aditya Birla Capital Ltd for additional loan

March 2026 Transactions:

• March 2, 2026: Multiple pledge releases totaling 2,99,459 shares across Deutsche Bank A.G, Aditya Birla Capital Ltd, Standard Chartered Capital Ltd, and HSBC InvestDirect Finance Service (India) Pvt Ltd
• March 4, 2026: Released 1,17,900 shares with Jio Finance Ltd and created pledge of 5,74,933 shares with Bajaj Finance Ltd
• March 5, 2026: Released 74,815 shares with Aditya Birla Capital Ltd

Current Shareholding Position

Following these transactions, the promoter's encumbered shareholding stands at 82,04,162 shares, representing 6.57% of the company's total share capital. The disclosure also provides a comprehensive overview of other promoter holdings in Ajanta Pharma Limited.

Financial Institution Partners

The pledge transactions involved multiple prominent financial institutions, demonstrating diversified lending relationships. The entities include Aditya Birla Capital Ltd, Deutsche Bank A.G, Bajaj Finance Ltd, Standard Chartered Capital Ltd, HSBC InvestDirect Finance Service (India) Pvt Ltd, and Jio Finance Ltd.

Regulatory Compliance

The disclosure was filed in accordance with Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The comprehensive filing includes detailed information about encumbrance creation, release, and the current status of pledged shares, ensuring full transparency with regulatory authorities and stakeholders.

Ajanta Pharma promoter Aayush Agrawal has disclosed simultaneous creation and release of pledge on 2,00,000 shares each with Aditya Birla Capital Ltd for loan management purposes. The transactions were formally communicated to BSE and NSE on February 20, 2026, in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Recent Pledge Transactions

Aayush Agrawal, acting as trustee of Aayush Agrawal Trust, executed two separate pledge transactions within a span of two days. The pledge release occurred on February 17, 2026, for loan repayment purposes, followed by a fresh pledge creation on February 19, 2026, to increase loan facilities.

Impact on Shareholding Pattern

Despite the pledge transactions, Aayush Agrawal's overall encumbered shareholding percentage remains unchanged at 6.60% of the company's total share capital. His total holding of 1,41,12,924 shares represents 11.30% of Ajanta Pharma's share capital.

Promoter Group Holdings

The disclosure reveals the comprehensive shareholding pattern of the promoter group. Other significant promoters maintain substantial stakes without any encumbrances on their holdings.

Key promoter holdings include:

• Yogesh M Agrawal Trust: 1,80,78,147 shares (14.47%)
• Rajesh M Agrawal Trust: 1,80,78,148 shares (14.47%)
• Ravi P Agrawal Trust: 1,62,42,904 shares (13.00%) with 60,63,920 shares (4.85%) encumbered
• Gabs Investments Pvt Ltd: 1,25,88,393 shares (10.08%)

Regulatory Compliance

The pledge transactions were disclosed in accordance with Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. The formal communication was submitted to both BSE and NSE, with copies provided to Ajanta Pharma Limited's company secretary. These transactions represent routine corporate financing arrangements where promoter shares serve as collateral for loan facilities with Aditya Birla Capital Ltd.